Pietro O. Annovazzi
Gallarate, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 04, 2026
Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.
Journal: The journal of headache and pain
Published: May 10, 2026
Pediatric Radiologically Isolated Syndrome (RIS): A Case with Active Disease 18 Years Later.
Journal: Neurology and therapy
Published: March 25, 2026
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
Journal: Frontiers in neurology
Published: March 13, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.
Journal: Neurology and therapy
Published: February 16, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
Journal: Journal of neurology
Published: December 05, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.
Journal: Neurology
Published: November 24, 2025
Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.
Journal: Journal of neurology
Published: November 18, 2025
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
Journal: Frontiers in neurology
Published: November 15, 2025
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study.
Journal: Neurology and therapy
Published: October 29, 2025
Last Updated: 09/26/2026